1887

Abstract

SUMMARY

The murine model of human cytomegalovirus infection was employed to analyse the kinetics of antibody production to murine cytomegalovirus (MCMV) structural and immediate early (IE) polypeptides following MCMV infection of genetically resistant and susceptible strains of mice. A total of 22 structural and six non-structural, IE proteins were identified. Analysis of immunoblots by densitometry identified four patterns of antibody reactivity to MCMV structural polypeptides during primary and secondary antibody responses over a period of 5 weeks post-infection (p.i.). Firstly, antibodies were strongly reactive with an 83K protein soon after infection, with levels which decreased with time; antibodies to a second group of viral proteins were also recognized soon after infection, but consistent levels of reactivity were maintained. Viral proteins that were recognized beyond day 14 p.i. or following a second MCMV infection formed the third group; the fourth group consisted of viral proteins that were detected at variable times p.i. by antisera from different mouse strains. The kinetics and intensity of the antibody response to individual viral proteins were influenced by virus dose, time p.i. and by a second MCMV infection. In addition, the genetic constitution of the host influenced the antibody response to MCMV proteins both quantitatively and qualitatively. In particular, sera from mice possessing C57BL but not BALB/c genes detected a 56K viral protein during seroconversion. Antibody reactivity to this protein was shown to segregate among sera from CXB mice, with a strain distribution pattern which indicated a linkage with the locus on chromosome 4. Finally, expression of the 56K protein was detected in B10.BR but not BALB/c embryo fibroblasts , with expression being a dominant trait in (BALB/c × B10.BR) F1 embryo fibroblasts. Thus, host genes may influence the expression of this structural viral protein.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-70-10-2573
1989-10-01
2022-01-23
Loading full text...

Full text loading...

/deliver/fulltext/jgv/70/10/JV0700102573.html?itemId=/content/journal/jgv/10.1099/0022-1317-70-10-2573&mimeType=html&fmt=ahah

References

  1. Allan J. E., Shellam G. R. 1984; Genetic control of murine cytomegalovirus infection: virus titres in resistant and susceptible strains of mice. Archives of Virology 81:139–150
    [Google Scholar]
  2. Bailey D. W. 1981; Recombinant inbred strains and bilineal congenic strains. In The Mouse in Biomedical Research 2223–239 Foster H.L., Small J. D., Fox J. G. New York: Academic Press;
    [Google Scholar]
  3. Bancroft G. J., Shellam G. R., Grundy J. E. 1981; Genetic influences on the augmentation of natural killer (NK) cells during murine cytomegalovirus infection: correlation with patterns of resistance. Journal of Immunology 126:988–994
    [Google Scholar]
  4. Blanton R. A., Tevethia M. J. 1981; Immunoprecipitation of virus-specific immediate-early and early polypeptides from cells lytically infected with human cytomegalovirus strain AD 169. Virology 112:262–273
    [Google Scholar]
  5. Bradford M. 1976; A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry 72:248–254
    [Google Scholar]
  6. Chalmer J. E., Mackenzie J. S., Stanley N. F. 1977; Resistance to murine cytomegalovirus linked to the major histocompatibility complex of the mouse. Journal of General Virology 37:107–114
    [Google Scholar]
  7. Chantler J. K., Hudson J. B. 1978; Proteins of murine cytomegalovirus: identification of structural and non-structural antigens in infected cells. Virology 86:22–26
    [Google Scholar]
  8. Dao M. L. 1985; An improved method of antigen detection on nitrocellulose: in situ staining of alkaline phosphatase conjugated antibody. Journal of Immunological Methods 82:225–231
    [Google Scholar]
  9. De Maeyer-Guignard J., Dandoy F., Bailey D. W., De Maeyer E. 1986; Interferon structural genes do not participate in quantitative regulation of interferon production by If loci as shown in C57BL/6 mice that are congenic with BALB/c mice at the alpha interferon gene cluster. Journal of Virology 58:743–747
    [Google Scholar]
  10. Friedman A. D., Michelson S., Plotkin S. A. 1982; Detection of antibodies to pre-early nuclear antigen and immediate-early antigens in patients immunized with cytomegalovirus vaccine. Infection and Immunity 38:1068–1072
    [Google Scholar]
  11. Gerna G., Cereda P. M., Cattaneo E., Achilli G., Revello M. G. 1978; Immunoglobulin G to virus-specific early antigens in congenital, primary and reactivated human cytomegalovirus infections. Infection and Immunity 22:833–841
    [Google Scholar]
  12. Gold D., Ashley R., Hunter Handsfield H., Verdon M., Leach L., Mills I., Drew L., Corey L. 1988; Immunoblot analysis of the humoral immune response in primary cytomegalovirus infection. Journal of Infectious Diseases 157:319–326
    [Google Scholar]
  13. Griffiths P. D., Grundy J. E. 1987; Molecular biology and immunology of cytomegalovirus. Biochemical Journal 241:313–324
    [Google Scholar]
  14. Grundy (chalmer) J. E., Melief C .J. M. 1982; Effect of Nu/Nu gene on genetically determined resistance to murine cytomegalovirus. Journal of General Virology 61:133–136
    [Google Scholar]
  15. Grundy (chalmer) J. E., Mackenzie J. S., Stanley N. F. 1981; Influence of H-2 and non-H-2 genes on resistance to murine cytomegalovirus infection. Infection and Immunity 32:277–286
    [Google Scholar]
  16. Grundy (Chalmer) J. E., Trapman J., Allan J. E., Shellam G. R., Melief C. J. M. 1982; Evidence for a protective role of interferon in resistance to murine cytomegalovirus and its control by non-H-2-linked genes. Infection and Immunity 37:143–150
    [Google Scholar]
  17. Harnett G. B., Shellam G. R. 1982; Variation in murine cytomegalovirus replication in fibroblasts from different mouse strains in vitro correlation with in vivo resistance. Journal of General Virology 62:39–47
    [Google Scholar]
  18. Harnett G. B., Shellam G. R. 1985; The role of interferon in the expression of genetically determined resistance to murine cytomegalovirus (MCMV). In Progress in Leukocyte Biology. Genetic Control of Host Resistance to Infection and Malignancy 3181–186 Skamene E. New York: Alan R. Liss;
    [Google Scholar]
  19. Hudson J. B. 1979; The murine cytomegalovirus as a model for the study of viral pathogenesis and persistent infections. Archives of Virology 62:1–29
    [Google Scholar]
  20. Jeang K -T., Gibson W. 1980; A cycloheximide enhanced protein in cytomegalovirus infected cells. Virology 107:362–374
    [Google Scholar]
  21. Jordan M. C. 1983; Latent infection and the elusive cytomegalovirus. Reviews of Infectious Diseases 5205–215
    [Google Scholar]
  22. Keil G. M., Fibi M. R., Koszinowski U. H. 1985; Characterization of the major immediate-early polypeptides encoded by murine cytomegalovirus. Journal of Virology 54:422–428
    [Google Scholar]
  23. Kim K. S., Sapienza V. J., Carp R. I., Moon H. M. 1976; Analysis of structural proteins of purified murine cytomegalovirus. Journal of Virology 17:906–915
    [Google Scholar]
  24. Koszinowski U. H., Reddehase M. J., Keil G. M., Schickedanz J. 1987; Host immune response to cytomegalovirus: products of transfected viral immediate-early genes are recognized by cloned cytolytic T lymphocytes. Journal of Virology 61:2054–2058
    [Google Scholar]
  25. Laemmli V. K. 1970; Cleavage of structural protein during the assembly of the head of bacteriophage T4. Nature London: 227680–685
    [Google Scholar]
  26. Landini M. P., Re M. C., Mirolo G., Baldassarri B., La Placa M. 1985; Human immune response to cytomegalovirus structural polypeptides studied by immunoblotting. Journal of Medical Virology 17:303–311
    [Google Scholar]
  27. Lawson C. M., Grundy J. E., Shellam G. R. 1987; Delayed-type hypersensitivity responses to murine cytomegalovirus in genetically resistant and susceptible strains of mice. Journal of General Virology 68:2379–2388
    [Google Scholar]
  28. Lawson C. M., Grundy J. E., Shellam G. R. 1988; Antibody responses to murine cytomegalovirus in genetically resistant and susceptible strains of mice. Journal of General Virology 69:1987–1998
    [Google Scholar]
  29. Musiani M., Landini M. P., Feletti C., La Placa M. 1978; Serum antibodies against cytomegalovirus-induced early and immediate early antigens and presence of viruria in renal transplant recipients. Microbiologica 1:101–105
    [Google Scholar]
  30. Osborn J. E. 1982; Cytomegalovirus and other herpesviruses. In The Mouse in Biomedical Research 294–106 Foster H. L, Small J. D., Fox J. G. New York: Academic Press;
    [Google Scholar]
  31. Pereira L., Hoffman M., Cremer N. 1982; Electrophoretic analysis of polypeptides immune precipitated from cytomegaiovirus-infected cell extracts by human sera. Infection and Immunity 36:933–942
    [Google Scholar]
  32. Pereira L., Stagno S., Hoffman M., Volanakis J. E. 1983; Cytomegaiovirus-infected cell polypeptides immune-precipitated by sera from children with congenital and perinatal infections. Infection and Immunity 39:100–108
    [Google Scholar]
  33. Porath A., Hanuka N., Keynan A., Sarov I. 1987; Virus-specific serum IgG, IgM, and IgA antibodies in cytomegalovirus mononucleosis patients as determined by immunoblotting technique. Journal of Medical Virology 22:223–230
    [Google Scholar]
  34. Price P., Winter J. G., Nikoletti S., Hudson J. B., Shellam G. R. 1987; Functional changes in murine macrophages infected with cytomegalovirus relate to H-2-determined sensitivity to infection. Journal of Virology 61:3602–3606
    [Google Scholar]
  35. Quinnan G. V., Manischewitz J. V. 1987; Genetically determined resistance to lethal murine cytomegalovirus infection is mediated by interferon-dependent and -independent restriction of virus replication. Journal of Virology 61:1875–1881
    [Google Scholar]
  36. Reddehase M. J., Koszinowski U. H. 1984; Significance of herpesvirus immediate early gene expression in cellular immunity to cytomegalovirus infection. Nature, London 312:369–371
    [Google Scholar]
  37. Reddehase M. J., Fibi M. R., Keil G. M., Koszinowski U. H. 1986; Late-phase expression of a murine cytomegalovirus immediate-early antigen recognized by cytolytic T lymphocytes. Journal of Virology 60:1125–1129
    [Google Scholar]
  38. Shellam G. R., Flexman J. P., Farrell H. E., Papadimitriou J. M. 1985; Genetic background modulates the effect of the beige and nude mutations on susceptibility to MCMV. In Progress in Leukocyte Biology. Genetic Control of Host Resistance to Infection and Malignancy 3175–180 Skamene E. New York: Alan R. Liss;
    [Google Scholar]
  39. Shimokawa K., Murayama T., Ishida S., Furukawa T. 1987; Analysis by immunoblotting of human cytomegalovirus antibody in sera of renal transplant recipient. Journal of Medical Virology 21:339–346
    [Google Scholar]
  40. The T. H., Anderson H. K., Spencer E. S., Klein G. 1977; Antibodies against cytomegalovirus-induced early antigens (CMV-EA) in immunosuppressed renal-allograft recipients. Clinical and Experimental Immunology 28:502–505
    [Google Scholar]
  41. Towbin H., Staehelin T., Gordon J. 1979; Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proceedings of the National Academy of SciencesU.S.A 76:4350–4354
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-70-10-2573
Loading
/content/journal/jgv/10.1099/0022-1317-70-10-2573
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error